China
· Delayed Price · Currency is CNY Beijing Balance Medical Technology Co.,Ltd. Statistics
Total Valuation
Beijing Balance Medical Technology Co.,Ltd. has a market cap or net worth of CNY 17.14 billion. The enterprise value is 16.76 billion.
| Market Cap | 17.14B |
| Enterprise Value | 16.76B |
Important Dates
The last earnings date was Wednesday, October 30, 2024.
| Earnings Date | Oct 30, 2024 |
| Ex-Dividend Date | May 28, 2024 |
Share Statistics
Beijing Balance Medical Technology Co.,Ltd. has 137.40 million shares outstanding. The number of shares has decreased by -0.64% in one year.
| Current Share Class | n/a |
| Shares Outstanding | 137.40M |
| Shares Change (YoY) | -0.64% |
| Shares Change (QoQ) | +5.12% |
| Owned by Insiders (%) | 67.63% |
| Owned by Institutions (%) | 10.68% |
| Float | 36.08M |
Valuation Ratios
The trailing PE ratio is 164.42 and the forward PE ratio is 105.75.
| PE Ratio | 164.42 |
| Forward PE | 105.75 |
| PS Ratio | 41.98 |
| PB Ratio | 14.63 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 166.03, with an EV/FCF ratio of -147.72.
| EV / Earnings | 161.82 |
| EV / Sales | 41.32 |
| EV / EBITDA | 166.03 |
| EV / EBIT | 200.51 |
| EV / FCF | -147.72 |
Financial Position
The company has a current ratio of 8.99, with a Debt / Equity ratio of 0.01.
| Current Ratio | 8.99 |
| Quick Ratio | 7.59 |
| Debt / Equity | 0.01 |
| Debt / EBITDA | 0.11 |
| Debt / FCF | -0.09 |
| Interest Coverage | 156.97 |
Financial Efficiency
Return on equity (ROE) is 7.85% and return on invested capital (ROIC) is 4.46%.
| Return on Equity (ROE) | 7.85% |
| Return on Assets (ROA) | 4.10% |
| Return on Capital (ROIC) | 4.46% |
| Revenue Per Employee | 857,445 |
| Profits Per Employee | 218,930 |
| Employee Count | 473 |
| Asset Turnover | 0.32 |
| Inventory Turnover | 1.02 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -8.65% in the last 52 weeks. The beta is 0.70, so Beijing Balance Medical Technology Co.,Ltd.'s price volatility has been lower than the market average.
| Beta (5Y) | 0.70 |
| 52-Week Price Change | -8.65% |
| 50-Day Moving Average | 113.86 |
| 200-Day Moving Average | 110.13 |
| Relative Strength Index (RSI) | 54.78 |
| Average Volume (20 Days) | 415,422 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Beijing Balance Medical Technology Co.,Ltd. had revenue of CNY 405.57 million and earned 103.55 million in profits. Earnings per share was 0.76.
| Revenue | 405.57M |
| Gross Profit | 361.07M |
| Operating Income | 83.57M |
| Pretax Income | 103.06M |
| Net Income | 103.55M |
| EBITDA | 98.42M |
| EBIT | 83.57M |
| Earnings Per Share (EPS) | 0.76 |
Balance Sheet
The company has 389.24 million in cash and 10.73 million in debt, giving a net cash position of 378.51 million or 2.75 per share.
| Cash & Cash Equivalents | 389.24M |
| Total Debt | 10.73M |
| Net Cash | 378.51M |
| Net Cash Per Share | 2.75 |
| Equity (Book Value) | 1.16B |
| Book Value Per Share | 8.53 |
| Working Capital | 526.70M |
Cash Flow
In the last 12 months, operating cash flow was 57.31 million and capital expenditures -170.74 million, giving a free cash flow of -113.44 million.
| Operating Cash Flow | 57.31M |
| Capital Expenditures | -170.74M |
| Free Cash Flow | -113.44M |
| FCF Per Share | -0.83 |
Margins
Gross margin is 89.03%, with operating and profit margins of 20.61% and 25.53%.
| Gross Margin | 89.03% |
| Operating Margin | 20.61% |
| Pretax Margin | 25.41% |
| Profit Margin | 25.53% |
| EBITDA Margin | 24.27% |
| EBIT Margin | 20.61% |
| FCF Margin | -27.97% |
Dividends & Yields
This stock pays an annual dividend of 0.80, which amounts to a dividend yield of 0.63%.
| Dividend Per Share | 0.80 |
| Dividend Yield | 0.63% |
| Dividend Growth (YoY) | 60.00% |
| Years of Dividend Growth | n/a |
| Payout Ratio | 105.51% |
| Buyback Yield | 0.64% |
| Shareholder Yield | 1.27% |
| Earnings Yield | 0.61% |
| FCF Yield | -0.66% |
Stock Splits
The last stock split was on May 26, 2022. It was a forward split with a ratio of 1.4.
| Last Split Date | May 26, 2022 |
| Split Type | Forward |
| Split Ratio | 1.4 |
Scores
Beijing Balance Medical Technology Co.,Ltd. has an Altman Z-Score of 79.98.
| Altman Z-Score | 79.98 |
| Piotroski F-Score | n/a |